Name: YD Bio Limited (YDES) Cash Flow Statement
Creator: FinSpry

YD Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for YD Bio Limited (YDES) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-1.41	0.01	-0.05
Depreciation & Amortization	0.10	0.00	0.00
Deferred Income Tax	0.03	0.00	0.00
Change in Working Capital	-0.57	-0.13	0.00
Change in Accounts Receivable	-0.01	-0.06	0.10
Change in Inventory	0.03	-0.03	0.00
Change in Accounts Payable	0.01	0.01	-0.01
Change in Other Working Capital	-0.60	-0.04	-0.08
Other Operating Activities	0.04	0.05	0.06
Net Cash from Operating Activities	-1.84	-0.06	0.07
Investing Activities
Capital Expenditures	-0.07	0.00	0.00
Purchases of Investments	0.01	0.00	-0.07
Sales/Maturities of Investments	-2.84	0.00	0.00
Other Investing Activities	-2.84	0.00	0.00
Net Cash from Investing Activities	-2.90	0.00	-0.07
Financing Activities
Debt Repayment	-0.13	-0.03	-0.08
Common Stock Issued	7.55	0.05	0.00
Other Financing Activities	-0.10	0.09	0.00
Net Cash from Financing Activities	7.73	0.11	-0.07
Summary
Effect of Forex Changes on Cash	0.06	0.00	0.00
Net Change in Cash	3.05	0.06	-0.08
Cash at Beginning of Period	0.09	0.03	0.00
Cash at End of Period	3.13	0.09	0.00
Free Cash Flow	-1.91	-0.06	0.07
Supplemental Disclosures
Interest Paid	0.00	0.00	0.00